These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 32063104)
1. Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol. Solana-Altabella A; Valero S; Balaguer J; Escobar-Cava P; Barranco H; López E; Ribes-Artero H; Poveda JL J Oncol Pharm Pract; 2020 Dec; 26(8):1829-1835. PubMed ID: 32063104 [TBL] [Abstract][Full Text] [Related]
2. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds. Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients. Bogan CM; Pierce JM; Doss SD; Tao YK; Chen SC; Boyd KL; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB Exp Eye Res; 2021 Mar; 204():108439. PubMed ID: 33444583 [TBL] [Abstract][Full Text] [Related]
4. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma. Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537 [TBL] [Abstract][Full Text] [Related]
5. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report. Chao A; Kao LY; Liu L; Wang NK BMC Ophthalmol; 2016 Mar; 16():27. PubMed ID: 26975871 [TBL] [Abstract][Full Text] [Related]
13. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture. Shields CL; Douglass AM; Beggache M; Say EA; Shields JA Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding. Sun YB; Hui P; Punyara K; Bi MC; Li SH; Teng SY; Song E Chin Med J (Engl); 2013; 126(8):1587. PubMed ID: 23595400 [No Abstract] [Full Text] [Related]
15. Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol. Valero García S; López Briz E; Escobar Cava P; Balaguer J; Pelufo A; Megías JE; Poveda Andrés JL J Oncol Pharm Pract; 2013 Jun; 19(2):159-64. PubMed ID: 23014898 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Ghassemi F; Shields CL Arch Ophthalmol; 2012 Oct; 130(10):1268-71. PubMed ID: 23044940 [TBL] [Abstract][Full Text] [Related]
17. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study. Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal injection of melphalan for intraocular retinoblastoma. Suzuki S; Aihara Y; Fujiwara M; Sano S; Kaneko A Jpn J Ophthalmol; 2015 May; 59(3):164-72. PubMed ID: 25808017 [TBL] [Abstract][Full Text] [Related]